folic acid has been researched along with Cardiotoxicity in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Huang, X; Li, N; Qiao, M; Song, L; Wang, F; Wang, T; Zhao, Y | 1 |
Brandt, MM; Cheng, C; Chrifi, I; de Boer, M; Duimel, H; Duncker, DJ; Fliegner, D; Janssens, S; Kararigas, G; Kietadisorn, R; Moens, AL; Octavia, Y; Swinnen, M; Verheyen, FK | 1 |
Eum, J; Hwang, BJ; Kee, Y; Ki, S; Kim, KN; Kwon, SH; Raslan, AA | 1 |
Dong, Y; Wu, Y; Xu, H; Zhang, C; Zhao, L | 1 |
Ahmad, S; Dubey, K; Fahim, M; Kohli, K; Panda, BP | 1 |
5 other study(ies) available for folic acid and Cardiotoxicity
Article | Year |
---|---|
Folic acid alleviates lead acetate-mediated cardiotoxicity by down-regulating the expression levels of Nrf2, HO-1, GRP78, and CHOP proteins.
Topics: Acetates; Animals; Cardiotoxicity; Endoplasmic Reticulum Chaperone BiP; Folic Acid; Glutathione Peroxidase; Heat-Shock Proteins; Lead; Male; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2022 |
Folic acid reduces doxorubicin-induced cardiomyopathy by modulating endothelial nitric oxide synthase.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Cardiomyopathies; Cardiotonic Agents; Cardiotoxicity; Doxorubicin; Folic Acid; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Mitochondria; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Stroke Volume; Superoxide Dismutase; Superoxides; Survival Analysis | 2017 |
3D light-sheet assay assessing novel valproate-associated cardiotoxicity and folic acid relief in zebrafish embryogenesis.
Topics: Animals; Biological Assay; Cardiotoxicity; Diagnostic Imaging; Embryo, Nonmammalian; Embryonic Development; Folic Acid; Heart Defects, Congenital; Intravital Microscopy; Myocytes, Cardiac; Valproic Acid; Zebrafish | 2019 |
Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay.
Topics: Animals; Antibiotics, Antineoplastic; Area Under Curve; Biological Availability; Cardiotoxicity; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Doxorubicin; Drug Carriers; Drug Monitoring; Female; Folic Acid; Half-Life; Heart Diseases; HeLa Cells; Humans; Injections, Intravenous; Metabolic Clearance Rate; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Polyesters; Risk Assessment; Tissue Distribution; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model.
Topics: Animals; Cardiotoxicity; Celecoxib; Disease Models, Animal; Folic Acid; Heart Failure; Male; Random Allocation; Rats; Rats, Wistar | 2017 |